Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma. [electronic resource]
Producer: 20100203Description: 150-7 p. digitalISSN:- 1535-5667
- Algorithms
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- metabolism
- Antineoplastic Agents -- administration & dosage
- Combined Modality Therapy
- Humans
- Image Processing, Computer-Assisted
- Indium Radioisotopes -- pharmacokinetics
- Isotope Labeling
- Lymphoma, Non-Hodgkin -- diagnostic imaging
- Organ Size -- physiology
- Positron-Emission Tomography
- Radiometry
- Radiopharmaceuticals -- pharmacokinetics
- Rituximab
- Tomography, X-Ray Computed
- Yttrium Radioisotopes
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.